22 May 2013
Keywords: fda, clears, astrazeneca, zomig, nasal, spray, food
Article | 13 October 2003
The US Food and Drug Administration has approved the use of AstraZeneca's Zomig (zolmitriptan) nasal spray (5mg) for the acute
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 October 2003
21 May 2013
© 2013 thepharmaletter.com